Skip to main navigation Skip to search Skip to main content

PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy

  • Koji Matsumoto
  • , Meiko Nishimura
  • , Takuma Onoe
  • , Hideki Sakai
  • , Yusaku Urakawa
  • , Takashi Onda
  • , Nobuo Yaegashi

Research output: Contribution to journal › Review article › peer-review

27   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases